UW Study to Use Cellectar Compound
Cellectar Biosciences’ CLR 131, its lead therapeutic compound, will be used in a University of Wisconsin study of neck and head cancers, the organization announced today. According to a release,…
Category Archives: Biotech
CDI Creates Business Divisions
Cellular Dynamics International announced today that it has created Therapeutics and Life Science business units to better serve its customers. “CDI and Fujifilm are firmly committed to the long-term potential of…
BioTechnique Begins Phase 2 of Partnership
BioTechnique, a specialty drug aseptic fill-finish contract manufacturing organization, will launch a second phase of manufacturing in partnership with a major, international not-for-profit organization, the company announced recently. “We are very…
Cologuard Included in Medicare Advantage Plans
The Centers for Medicare and Medicaid Services (CMS) announced recently that patients with Medicare Advantage plans must include coverage of Exact Sciences’ Cologuard every three years without cost sharing. “The…
HCSC, Florida Blue to Cover Cologuard
Exact Sciences continues to expand its coverage of Cologuard as Health Care Service Corp (HCSC) and Florida Blue recently updated their medical policies to cover the noninvasive stool DNA screen…
EyeKor Raises $600,000
Story provided by Polo Rocha, WisBusiness.com Madison-based EyeKor is planning an expansion of its platform after closing a $600,000 fundraising round. The company, which disclosed the news in an SEC filing,…
Cellectar Earns $2M SBIR Contract
Cellectar Biosciences announced today it is the recipient of the second phase of a National Cancer Institute Fast-Track SBIR contract worth $2 million. According to a release, the money will be used to…
FluGen Starts Clinical Trial of Vaccine
FluGen announced today it has begun a Phase I clinical trial of its universal influenza vaccine called RedeeFlu. “The initiation of this first-in-man study is an important milestone achieved through…
HEDIS Quality Measures May Include Cologuard
Exact Sciences announced this week that Cologuard could be included in the 2017 Healthcare Effectiveness Data and Information Set (HEDIS) quality measures for colorectal cancer screening following a proposal from the…
SHINE, HTA to Collaborate
SHINE Medical Technologies announced today that is has entered into a strategic agreement with the largest Chinese producer and distributor of radio-pharmaceuticals, HTA, to help with the supply of molybdenum (moly-99). “HTA…
